Cerebrovascular Accident Clinical Trial
Official title:
Analysis of the Electrical Muscle Activity and Resistance to Movement After Pplication Neuromuscular Electrical Stimulation (EENM) in Patients With Hemiparesis Spastic.
To evaluate and compare the effects of Neuromuscular Electrical Stimulation when applied in
the agonist and antagonist muscles of spastic hemiparetic patients.
The specific objectives are:
- Evaluate the resistance movement, strength and muscle electrical activity before and
after application of Neuromuscular Electrical Stimulation in spastic muscle
(gastrocnemius).
- Evaluate the resistance movement, strength and muscle electrical activity before and
after application of Neuromuscular Electrical Stimulation in the spastic antagonist
muscle (tibialis anterior).
- Compare the risk of falls after application of Neuromuscular Electrical Stimulation in
both muscles studied.
Most hemiparetic patients can develop spasticity, characterized by neuronal
hyperexcitability, increased resistance to passive stretch, Babinski sign, clonus, reflexes
and involuntary spasms skin.
As a consequence, there may be contractures and muscle shortening, generating functional
limitations. Neuromuscular Electrical Stimulation feature that can control the spasticity
through reciprocal inhibition, muscle relaxation and sensory stimulation. The goal will be
to evaluate and compare the effects of neuromuscular electrical stimulation when applied in
the agonist and antagonist muscles of spastic hemiparetic patients.
;
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05477238 -
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
|
N/A | |
| Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
| Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
| Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
| Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
| Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
| Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
| Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
| Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
| Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
| Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
| Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
| Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
| Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
| Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
| Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
| Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
| Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
| Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
| Completed |
NCT00149435 -
Cardiovascular Health Study (CHS) Events Follow-up Study
|